Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype?


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
06 Aug 2021
Historique:
received: 21 05 2021
accepted: 26 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 20 8 2021
Statut: epublish

Résumé

The COVID-19 pandemic has resulted in significant acute morbidity and mortality worldwide. There is now a growing recognition of the longer-term sequelae of this infection, termed "long COVID". However, little is known about this condition. Here, we describe a distinct phenotype seen in a subset of patients with long COVID who have reduced exercise tolerance as measured by the 6 min walk test. They are associated with significant exertional dyspnea, reduced health-related quality of life and poor functional status. However, surprisingly, they do not appear to have any major pulmonary function abnormalities or increased burden of neurologic, musculoskeletal or fatigue symptoms.

Identifiants

pubmed: 34362372
doi: 10.1186/s12931-021-01814-9
pii: 10.1186/s12931-021-01814-9
pmc: PMC8343348
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

222

Informations de copyright

© 2021. The Author(s).

Références

Eur Respir J. 2021 Feb 25;57(2):
pubmed: 33479105
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7
pubmed: 9817683
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
JAMA. 2020 Nov 3;324(17):1723-1724
pubmed: 33031513

Auteurs

Grace Y Lam (GY)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, 3-111C Clinical Sciences Building, 11302 83 Ave NW, Edmonton, AB, T6G 2G3, Canada. glam@ualberta.ca.
Alberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada. glam@ualberta.ca.

A Dean Befus (AD)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, 3-111C Clinical Sciences Building, 11302 83 Ave NW, Edmonton, AB, T6G 2G3, Canada.
Alberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada.

Ronald W Damant (RW)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, 3-111C Clinical Sciences Building, 11302 83 Ave NW, Edmonton, AB, T6G 2G3, Canada.
Alberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada.

Giovanni Ferrara (G)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, 3-111C Clinical Sciences Building, 11302 83 Ave NW, Edmonton, AB, T6G 2G3, Canada.
Alberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada.

Desi P Fuhr (DP)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, 3-111C Clinical Sciences Building, 11302 83 Ave NW, Edmonton, AB, T6G 2G3, Canada.

Michael K Stickland (MK)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, 3-111C Clinical Sciences Building, 11302 83 Ave NW, Edmonton, AB, T6G 2G3, Canada.
Alberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada.

Rhea A Varughese (RA)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, 3-111C Clinical Sciences Building, 11302 83 Ave NW, Edmonton, AB, T6G 2G3, Canada.
Alberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada.

Eric Y Wong (EY)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, 3-111C Clinical Sciences Building, 11302 83 Ave NW, Edmonton, AB, T6G 2G3, Canada.
Alberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada.

Maeve P Smith (MP)

Division of Pulmonary Medicine, Department of Medicine, University of Alberta and Alberta Health Services, 3-111C Clinical Sciences Building, 11302 83 Ave NW, Edmonton, AB, T6G 2G3, Canada.
Alberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH